Precision BioSciences Activates First Clinical Trial Site and Begins Patient Enrollment in Phase 1/2 FUNCTION-DMD Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. APTX:CN
3. IQMX
4. EROC
5. SEER
6. FRBT
7. MSTR
8. SPGI
9. ONDS
10. USO

Go back to Precision BioSciences Activates First Clinical Trial Site and Begins Patient Enrollment in Phase 1/2 FUNCTION-DMD Study
(NASDAQ: DTIL) Delayed: 8.18 --0 (-0%)
Previous Close $8.18    52 Week High $ 
Open $1.39    52 Week Low $ 
Day High $8.18    P/E N/A 
Day Low $8.18    EPS $ 
Volume 38